{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:52:01Z","timestamp":1787064721656,"version":"build-2736575974"},"reference-count":19,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,8]]},"DOI":"10.31744\/einstein_journal\/2025ao1437","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T14:59:10Z","timestamp":1754924350000},"source":"Crossref","is-referenced-by-count":4,"title":["Transrectal prostate biopsy complications: a prospective single center study in a mid-income country"],"prefix":"10.31744","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2757-3374","authenticated-orcid":false,"given":"Allan Jefferson","family":"Schollemberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4321-0078","authenticated-orcid":false,"given":"Flavio Lobo","family":"Heldwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9977-7941","authenticated-orcid":false,"given":"Suelen dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0716-2024","authenticated-orcid":false,"given":"V\u00edtor Maur\u00edcio Merlin","family":"Maschietto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7579-2899","authenticated-orcid":false,"given":"Erick","family":"Schnorrenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1975-8655","authenticated-orcid":false,"given":"Kleber","family":"Reinert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1453-7816","authenticated-orcid":false,"given":"Gabriela Garcia","family":"Korczaguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6835-9085","authenticated-orcid":false,"given":"Marcelo Langer","family":"Wroclawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16942","reference":[{"issue":"1","key":"key20250811145902_B1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","unstructured":"1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12-49.","journal-title":"CA Cancer J Clin"},{"issue":"10437","key":"key20250811145902_B2","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The Lancet Commission on prostate cancer: planning for the surge in cases","volume":"403","author":"James","year":"2024","unstructured":"2. James ND, Tannock I, N'Dow J, Feng F, Gillessen S, Ali SA, et al. The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet. 2024;403(10437):1683-722.","journal-title":"Lancet"},{"key":"key20250811145902_B3","author":"Instituto Nacional de C\u00e2ncer Jos\u00e9 Alencar Gomes da Silva (INCA)","year":"2019","unstructured":"3. Instituto Nacional de C\u00e2ncer Jos\u00e9 Alencar Gomes da Silva (INCA). Estimativa 2020: incid\u00eancia de c\u00e2ncer no Brasil. Rio de Janeiro: INCA; 2019.","journal-title":"Estimativa 2020: incid\u00eancia de c\u00e2ncer no Brasil"},{"key":"key20250811145902_B4","author":"Cornford","year":"2024","unstructured":"4. Cornford P, Briers E, De Meerleer G, De Santis M, Eberli D, Sommer S, et al. EAU Prostate Cancer Guidelines. Arnhem, The Netherlands: EAU Guidelines Office; 2024 [cited 2025 Fab 3]. Available from: https:\/\/uroweb.org\/guidelines\/prostate-cancer","journal-title":"EAU Prostate Cancer Guidelines"},{"issue":"8","key":"key20250811145902_B5","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00345-015-1722-1","article-title":"Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003-2013","volume":"34","author":"Tandogdu","year":"2016","unstructured":"5. Tandogdu Z, Bartoletti R, Cai T, \u00c7ek M, Grabe M, Kulchavenya E, et al. Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003-2013. World J Urol. 2016;34(8):1193-200.","journal-title":"World J Urol"},{"issue":"3","key":"key20250811145902_B6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.eururo.2012.06.003","article-title":"Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study","volume":"63","author":"Wagenlehner","year":"2013","unstructured":"6. Wagenlehner FM, van Oostrum E, Tenke P, Tandogdu Z, \u00c7ek M, Grabe M, Wullt B, Pickard R, Naber KG, Pilatz A, Weidner W, Bjerklund-Johansen TE; GPIU investigators. Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol. 2013;63(3):521-7.","journal-title":"Eur Urol"},{"issue":"4","key":"key20250811145902_B7","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/ijc.24326","article-title":"Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort","volume":"125","author":"Johnsen","year":"2009","unstructured":"7. Johnsen NF, Tj\u00f8nneland A, Thomsen BL, Christensen J, Loft S, Friedenreich C, et al. Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int J Cancer. 2009;125(4):902-8.","journal-title":"Int J Cancer"},{"issue":"2","key":"key20250811145902_B8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/JU.0000000000003788","article-title":"Complications Following Transrectal and Transperineal Prostate Biopsy: Results of the ProBE-PC Randomized Clinical Trial","volume":"211","author":"Mian","year":"2024","unstructured":"8. Mian BM, Feustel PJ, Aziz A, Kaufman RP Jr, Bernstein A, Avulova S, et al. Complications Following Transrectal and Transperineal Prostate Biopsy: Results of the ProBE-PC Randomized Clinical Trial. J Urol. 2024;211(2):205-13.","journal-title":"J Urol"},{"issue":"4","key":"key20250811145902_B9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/(SICI)1097-0045(19990601)39:4<316::AID-PROS14>3.0.CO;2-O","article-title":"Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region)","volume":"39","author":"Kranse","year":"1999","unstructured":"9. Kranse R, Beemsterboer P, Rietbergen J, Habbema D, Hugosson J, Schr\u00f6der FH. Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region). Prostate. 1999;39(4):316-22.","journal-title":"Prostate"},{"issue":"1","key":"key20250811145902_B10","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens5010010","article-title":"The Global Prevalence of Infections in Urology Study: A Long-Term, Worldwide Surveillance Study on Urological Infections","volume":"5","author":"Wagenlehner","year":"2016","unstructured":"10. Wagenlehner F, Tandogdu Z, Bartoletti R, Cai T, Cek M, Kulchavenya E, et al. The Global Prevalence of Infections in Urology Study: A Long-Term, Worldwide Surveillance Study on Urological Infections. Pathogens. 2016;5(1):10.","journal-title":"Pathogens"},{"issue":"3","key":"key20250811145902_B11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.juro.2009.11.043","article-title":"Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy","volume":"183","author":"Nam","year":"2010","unstructured":"11. Nam RK, Saskin R, Lee Y, Liu Y, Law C, Klotz LH, et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol. 2010;183(3):963-8.","journal-title":"J Urol"},{"issue":"6","key":"key20250811145902_B12","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s00345-013-1218-9","article-title":"Healthcare-associated urinary tract infections in hospitalized urological patients-a global perspective: results from the GPIU studies 2003-2010","volume":"32","author":"Cek","year":"2014","unstructured":"12. Cek M, Tandogdu Z, Wagenlehner F, Tenke P, Naber K, Bjerklund-Johansen TE. Healthcare-associated urinary tract infections in hospitalized urological patients-a global perspective: results from the GPIU studies 2003-2010. World J Urol. 2014;32(6):1587-94.","journal-title":"World J Urol"},{"issue":"10","key":"key20250811145902_B13","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1464-410X.2010.09948.x","article-title":"Antibiotics and observation have a similar impact on asymptomatic patients with a raised PSA","volume":"107","author":"Heldwein","year":"2011","unstructured":"13. Heldwein FL, Teloken PE, Hartmann AA, Rhoden EL, Teloken C. Antibiotics and observation have a similar impact on asymptomatic patients with a raised PSA. BJU Int. 2011;107(10):1576-81.","journal-title":"BJU Int"},{"issue":"8031","key":"key20250811145902_B14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/d41586-024-03033-w","article-title":"40 million deaths by 2050: toll of drug-resistant infections to rise by 70","volume":"633","author":"Naddaf","year":"2024","unstructured":"14. Naddaf M. 40 million deaths by 2050: toll of drug-resistant infections to rise by 70. Nature. 2024;633(8031):747-8.","journal-title":"Nature"},{"issue":"8","key":"key20250811145902_B15","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/bco2.366","article-title":"Perioperative alpha blockers in voiding dysfunction secondary to prostate biopsy: A meta-analysis","volume":"5","author":"Lim","year":"2024","unstructured":"15. Lim S, Lim KY, Qu L, Ranasinha S, Dat A, Brown M, et al. Perioperative alpha blockers in voiding dysfunction secondary to prostate biopsy: A meta-analysis. BJUI Compass. 2024;5(8):748-60.","journal-title":"BJUI Compass"},{"issue":"3","key":"key20250811145902_B16","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s11255-023-03854-0","article-title":"Risk factors for infection and acute urinary retention following transperineal prostate biopsy","volume":"56","author":"Sandberg","year":"2024","unstructured":"16. Sandberg M, Whitman W, Greenberg J, Hingu J, Thakker P, Rong A, et al. Risk factors for infection and acute urinary retention following transperineal prostate biopsy. Int Urol Nephrol. 2024;56(3):819-26.","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"key20250811145902_B17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.23736\/S2724-6051.22.05043-1","article-title":"Survey on prostate MRI reading and interpretation among urology residents in Italy, Brazil and the UK: a cry for help","volume":"75","author":"Ippoliti","year":"2023","unstructured":"17. Ippoliti S, Orecchia L, Esperto F, Wroclawski ML, Manenti G, Barrett T, et al. Survey on prostate MRI reading and interpretation among urology residents in Italy, Brazil and the UK: a cry for help. Minerva Urol Nephrol. 2023;75(3):297-307.","journal-title":"Minerva Urol Nephrol"},{"issue":"5","key":"key20250811145902_B18","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.juro.2011.06.057","article-title":"Complications after prostate biopsy: data from SEER-Medicare","volume":"186","author":"Loeb","year":"2011","unstructured":"18. Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM. Complications after prostate biopsy: data from SEER-Medicare. J Urol. 2011;186(5):1830-4.","journal-title":"J Urol"},{"issue":"2","key":"key20250811145902_B19","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.eururo.2012.09.038","article-title":"Antibiotic prophylaxis in urology departments, 2005-2010","volume":"63","author":"\u00c7ek","year":"2013","unstructured":"19. \u00c7ek M, Tandogdu Z, Naber K, Tenke P, Wagenlehner F, van Oostrum E, Kristensen B, Bjerklund Johansen TE; Global Prevalence Study of Infections in Urology Investigators. Antibiotic prophylaxis in urology departments, 2005-2010. Eur Urol. 2013;63(2):386-94.","journal-title":"Eur Urol"}],"container-title":["einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T14:59:12Z","timestamp":1754924352000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/transrectal-prostate-biopsy-complications-a-prospective-single-center-study-in-a-mid-income-country\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":19,"alternative-id":["10.31744\/einstein_journal\/2025AO1437"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2025ao1437","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"value":"1679-4508","type":"print"},{"value":"2317-6385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"eAO1437"}}